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Angiogenesis is a pivotal event in endochondral ossi®cation. Vessels grow into the hypertrophic cartilage and erode it to
produce a scaffold on which osteoblasts settle to produce woven bone. A new culture system was used to determine
whether growth-plate chondrocytes produce an angiogenic molecule. Chondrocytes from primary growth plates of bovine
fetuses were separated into maturationally distinct subpopulations. When cultured these cells produce an extensive extracel-
lular matrix and the prehypertrophic cells mature to express the hypertrophic phenotype de®ned by the synthesis of type
X collagen and matrix calci®cation. The culture medium collected from the hypertrophic cells contains a chemoattractant,
nonmitogenic molecule for bovine endothelial cells which can induce angiogenesis in vivo in the rabbit cornea model.
This molecule has a Mr of approximately 120 1 103. The production of this molecule by hypertrophic cells is enhanced
by both 1,25-(OH)2 vitamin D3 and 24,25-(OH)2 vitamin D3 at 1008±10012 M, but only in pre- and early hypertrophic cells.
In contrast, these metabolites have either no effect or an inhibitory effect on the more mature hypertrophic cells. These
results describe for the ®rst time the production of an angiogenic molecule by hypertrophic chondrocytes. They demonstrate
an important role for vitamin-D3 metabolites in regulating hypertrophy and angiogenesis during normal skeletal growth
and differentiation. Thus, a defective regulation of these processes, due to the lack of vitamin-D metabolites, may explain
the observed enlargement of the hypertrophic zone and impairment of skeletal growth in rickets which is induced clinically
and experimentally by a de®ciency of vitamin D. q 1996 Academic Press, Inc.
INTRODUCTION curs. At the junction of the metaphysis with the hypertro-
phic zone of the growth plate, capillaries from the devel-
oping bone invade the uncalci®ed and calci®ed cartilage ofAngiogenesis is a fundamental biological process whereby
the physis which results in the subsequent removal of thenew capillaries are formed (Folkman, 1991; Folkman and
cartilage and its replacement by bone (Schenk et al., 1967,Shing, 1992). It is an essential process in reproduction,
1968). Despite the fundamental importance of this processwound repair, and skeletal development where ordinarily
for endochondral bone formation, our understanding of thisit is switched on at a precise stage by angiogenic molecules.
angiogenic process is extremely limited.However, persistent uncontrolled angiogenesis can contrib-
A number of angiogenic molecules, such as basic ®bro-ute to the pathogenesis of a number of diseases such as
blast growth factor (bFGF), transforming growth factor-bretinopathy, tumor growth and metastasis, rheumatoid ar-
(TGFb) (Gelb et al., 1990; Jingushi et al., 1989), and a low-thritis, and osteoarthritis (Brown and Weiss, 1988; Colville-
molecular-weight angiogenic factor known as endothelialNash and Scott, 1992; Folkman, 1991).
cell-stimulating factor (ESAF) (Brown et al., 1987), haveCartilage is a predominantly avascular tissue except dur-
been shown to be present in growth-plate cartilage. Theseing development when endochondral bone formation oc-
molecules could act as potential chemoattractants for endo-
thelial cells. Following the release of chemotactic mole-
cules, a cascade of events that characterize angiogenesis1 Present address: Department of Orthopaedics, Medical School,
Kobe University, Chuo-ku, Kobe, 650, Japan. occurs. These include degradation and remodeling of the
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coated 25-cm2 ¯asks at 377C with DMEM supplemented with 10%matrix, migration and proliferation of endothelial cells, in-
FCS. After 18±24 hr nonadherent cells were removed from the ¯askvasion of the uncalci®ed transverse septum cartilage, and
and fresh medium was added. Cells from passages 3±6 were usedvessel maturation. These processes continue during devel-
for the Boyden chamber assays. The endothelial nature of the cellsopment until growth-plate closure occurs at the end of pu-
was con®rmed by staining with an antiserum to factor VIII-relatedberty, again due to mechanisms that remain unknown.
antigen (Dakopatts, Glastrup, Denmark) (Hoyer et al., 1973).
During skeletal development, vitamin-D3 de®ciency Type X collagen synthesis. Type X collagen synthesis was mea-
leads to impaired skeletal growth with a well-recognized sured during culture under serum-free conditions as previously de-
elongation of the hypertrophic zone of the physis, character- scribed (Alini et al., 1994). Twenty-®ve mCi/ml of [3H]proline (Am-
istic of the condition called rickets (Pitt, 1988). These ersham Canada Inc.) and 70 mg/ml b-amino-proprionitrile were
changes could result from impairment of a vitamin-D3-de- added for 48 hr to the culture medium as indicated. Radiolabeled
pendent angiogenesis. culture media (shown previously to be representative of cell layer
biosynthesis of type X collagen) (Alini et al., 1994) were precipitatedRecently we reported the isolation of growth-plate chon-
by ammonium sulfate (33% saturation) overnight at 47C. Pelletsdrocytes from the fetal bovine physis into maturationally
were washed twice with 70% ethanol and analyzed directly bydistinct subpopulations using Percoll density gradient cen-
sodium dodecyl sulfate±polyacrylamide gel electrophoresis (SDS±trifugation (Lee et al., 1990; Alini et al., 1994). When cul-
PAGE) (Laemmli, 1970) using 7.5% gels followed by ¯uorographytured at high density these cells divide, establish an extra-
(Laskey and Hills, 1975).
cellular matrix, and then mature to express the hypertro-
Vitamin-D3 metabolites. Either 1,25-(OH)2D3 or 24,25-(OH)2D3phic phenotype de®ned by the synthesis of type X collagen or both metabolites (at 1008, 10010, or 10012 M) were added for 48
followed by matrix calci®cation (Alini et al., 1994). This hr in serum-free medium as indicated above. Control wells received
report describes the use of the culture system to demon- the highest amounts (less than 1%) of vehicle (ethanol). Serum-
strate that hypertrophic growth-plate chondrocytes produce free media were stored at 0207C prior to assay for endothelial cell
a previously undescribed angiogenic molecule, the produc- chemotactic activity.
Endothelial cell chemotaxis assay. EC migration was mea-tion of which is regulated by metabolites of vitamin D3.
sured using a modi®ed Boyden chamber assay (Neuroprobe, Inc.,
Bethesda, MD) as described by Falk et al. (1980). Polycarbonate
membranes with 8-mm pores (Nucleopore Corp., Pleasanton, CA)
MATERIALS AND METHODS were precoated by the manufacturer with gelatin. Culture media
were assayed at the end of the 48-hr serum-free culture. Increasing
concentrations of serum-free medium obtained from chondrocyteChondrocyte culture. Bovine fetal growth-plate chondrocytes
subpopulations at different stages of maturation were added to thewere isolated and fractionated into subpopulations, as previously
lower wells (30 ml). The upper wells (40 ml) received EC at a densitydescribed (Lee et al., 1990; Alini et al., 1994), except that reduced
of 2 1 104 cells/well. The chambers were incubated at 377C withconcentrations of enzymes were used, namely 800 mg/ml collagen-
6.5% CO2 in air for 5 to 6 hr. At the end of the incubation time,ase (type IA, Sigma Chemical Co., St. Louis, MO), 300 mg/ml hyal-
the cells on the upper surface of the membrane were removed byuronidase (ovine testicular type V, Sigma Chemical Co.), and 50
drawing the membrane over the edge of a glass plate. The cellsmg/ml DNAse I (from bovine pancreas, Sigma Chemical Co.), in
which had migrated through the membrane onto the lower surfaceorder to increase the recovery and viability (over 80%) of subpopula-
were ®xed in 100% methanol and stained with Mayer's hematoxy-tion A (the least dense and the largest cells). Four chondrocyte
lin. Migration was quanti®ed by counting the number of EC thatsubpopulations (A, B, C, and D/E) were seeded on gelatin-coated
had migrated to the lower surface of the polycarbonate membrane96-well ¯at-bottom microtiter plates (Falcon, Becton Dickinson,
using a Photomicroscope III (Carl Zeiss Inc., MontreÂal). Between 7NJ) at a density of 2 1 105 cells in 200 ml medium per well. The cells
and 10 ®elds (total area 7.1 mm2) were counted. These determina-were cultured in Dulbecco's modi®ed Eagle's medium (DMEM)
tions were performed in triplicate (mean { S.D. are shown). Tosupplemented with 10% fetal calf serum (FCS), containing 50 mg/
determine whether the migration of EC was due to movementml ascorbic acid and 5 mM sodium b-glycerophosphate (both addi-
along a concentration gradient (chemotaxis) or random migrationtives were freshly prepared at each medium change). To avoid the
(chemokinesis), checkerboard analysis was performed (Zigmondinterference of FCS during the chemotactic assay, cells were also
and Hirsh, 1973) by adding various concentrations of the chondro-cultured for 48-hr periods (Days 0±2, 2±4, 4±6, 6±8) in serum-free
cyte serum-free medium to the upper wells together with the EC.DMEM, containing 5 mg/ml insulin, 5 mg/ml transferrin, 5 ng/ml
Cell proliferation assay. Endothelial cells obtained by trypsinsodium selenite (ITS), 1 mg/ml fatty acid-free bovine serum albu-
treatment of con¯uent monolayers (passage 3±6) were plated onmin (BSA), ascorbic acid, and sodium b-glycerophosphate (as above)
gelatin-coated 96-well ¯at-bottom microtiter plates at a density ofwith or without vitamin-D3 metabolites as indicated below. Only
2 1 104 cells/well in DMEM supplemented with 10% FCS. At 90%serum-free media were examined for chemotactic activity.
con¯uence, different concentrations of chemotactic-positive HPLCEndothelial cell culture. Endothelial cells (EC) were obtained
fractions were added (in triplicate) under serum-free conditions andfrom bovine umbilical veins as previously described (Jaffe et al.,
incubated for a further 48 hr. [3H]Thymidine (1 mCi) was added to1973). Brie¯y, umbilical veins were washed several times with
each well for the last 18 hr prior to EC isolation using trypsin andDMEM and infused with 1% collagenase (type 1A, Sigma Chemical
collected with a Titertek cell harvester (Skatron, Sterling, VA) ontoCo.) in DMEM containing 10% FCS for 15 min at room temperature
glass ®ber ®lter papers. Incorporated radioactivity was measured(by clamping the ends of the veins). The collagenase solution con-
by liquid scintillation counting (Packard, Meriden, CT).taining detached EC was removed and the cells were washed several
Puri®cation of chemotactic/angiogenic molecule. Chemotac-times with DMEM containing 0.25 mg/ml fungizone (Gibco BRL,
Grand Island, NY). Endothelial cells were cultured on gelatin- tic-positive chondrocyte-conditioned serum-free media (up to 500
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ml) were concentrated using a YM-1 membrane (molecular weight
cutoff 1000; Amicon, Beverly, MA). The retentate (reconstituted to
its original volume with DMEM) and the ®ltrate were stored at
0207C until they were examined for chemotactic activity in the
Boyden chamber assay. Chemotactic activity was found to be to-
tally bound to the membrane. The activity was eluted with 2 M
NaCl in 10 mM Tris±HCl, pH 7.4, overnight at 47C, lyophilized,
and desalted by washing with 70% ethanol. The residue was dis-
solved in water and examined for chemotactic activity. The posi-
tive residue was adjusted to 0.1% tri¯uoroacetic acid (TFA) (maxi-
mal volume of 1 ml) and chromatographed with high-performance
liquid chromatography (HPLC) using a C18 mBondapak column (3.9
1 300 mm) (Waters). The column was developed with 100% solvent
A (0.1% TFA) for 10 min, followed by a linear gradient (from 0 to
100%) of solvent B (0.1% TFA in 80% acetonitrile) over a 60-min
period. The eluate was monitored at 214 and 280 nm. Fractions
(1.5 ml) were pooled (as indicated under Results), lyophilized,
washed with 70% ethanol, redissolved in water, and evaluated for
endothelial cell chemotactic activity in vitro and angiogenesis in
vivo.
Angiogenesis assay. The rabbit cornea assay (Gimbrone et al.,
1974) was utilized to determine if the chemotactic molecule was
also angiogenic in vivo.
After partial puri®cation using HPLC (as described above), che-
motactic-positive fractions were mixed in a hydroxyethyl-methac-
rylate polymer (Polyscience Inc. Warrington, Hampshire, UK) in
70% ethanol at room temperature as described (Langer and Folk-
man, 1976). The molecule trapped within the polymer matrix was
implanted as a pellet of 1 mm3 in the rabbit cornea stroma (New
Zealand white, female, 3±4 kg) 2 mm away from the corneal±
FIG. 1. A comparison of type X collagen synthesis in the differentscleral junction. Basic FGF was used as positive control. The cor-
chondrocyte subpopulations with cellular maturation. Culture me-neas were examined every 2 days to monitor for infection and capil-
dia of chondrocyte subpopulations A, B, C, and D/E (data notlary growth. The rabbits were sacri®ced 10 days after implantation.
shown) at Days 2, 4, 6, 8, 10, and 12 were analyzed using SDS±Just prior to euthanasia some of the rabbits were perfused from the
PAGE and ¯uorography as indicated under Materials and Methods.carotoid artery with colloidal carbon to improve de®nition of the
The same number of wells (n  2) were analyzed at each time pointnew corneal vessels. For histological examination, entire anterior
(fetal age, 210 days). The location of type X collagen is shownsegments (cornea and iris) were excised and ®xed with 10% forma-
(arrow), having been identi®ed as described previously (Alini et al.,lin for 24 hr. Paraf®n wax-embedded sections (6 mm) were stained
1994).with hematoxylin and eosin and examined using light microscopy.
SDS±PAGE followed by elution from polyvinylidene ¯uoride
(PVDF) membrane. Chemotactic-positive HPLC fractions were
pooled, lyophilized, washed twice with 70% ethanol, and analyzed
those previously used, it was possible to increase the viabil-by SDS±PAGE using 4±20% gradient gels. Following electrophore-
sis, proteins were either stained directly with Coomassie blue or ity of the largest and most mature subpopulation A from
transferred to PVDF membrane in the presence of 10 mM 3-(cyclo- 20±30% to above 80%. There was no decrease in the num-
hexylamino)-1-propanesulfonic acid (CAPS) buffer, pH 11.0, for 2 ber of cells recovered in the other subpopulations except
hr at 60 V. Transferred protein was visualized temporarily with for the smallest, least mature, and densest subpopulation E
Ponceau red stain and the required molecular weight band excised. (Alini et al., 1994). The latter was pooled together with
Controls were BSA and blank gel transfers. To elute the transferred subpopulation D for the subsequent experiments.
protein from the membrane, excised PVDF pieces were incubated
All chondrocyte subpopulations adhered to the gelatin-overnight at 377C with 100 mM Tris±HCl, pH 8.5, containing 40%
coated wells after 4±6 hr of culture, losing their roundedacetonitrile, followed by a 30-min incubation at 507C with 0.05%
shape and assuming a polygonal appearance. They demon-TFA in 40% acetonitrile. Eluents were combined, lyophilized,
strated a characteristic ``cobblestone'' morphology. As pre-washed with 70% ethanol, and tested for chemotactic activity in
vitro. viously described (Alini et al., 1994) the cells rapidly synthe-
Protein determination. A ¯uorometric assay employing ¯u- sized an extensive extracellular matrix rich in collagen and
orescamine was used as previously described (BoÈhlen et al., 1973). proteoglycan. Type X collagen, a de®nitive marker for the
hypertrophic phenotype, was detected in the serum-free me-
dium (DMEM-ITS) of subpopulation A within 2±4 days ofRESULTS
isolation (Fig. 1). At this stage these cells are, by de®nition,
hypertrophic chondrocytes. After progressively longer peri-Chondrocyte primary cultures. By reducing the enzyme
concentrations used to isolate chondrocytes compared to ods of culture in the presence of 10% FCS, type X collagen
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mine if this was dependent on their stage of maturational
development, chondrocyte serum-free conditioned media
were analyzed using the Boyden chamber assay after differ-
ent periods of exposure to FCS.
An example of a positive and a negative chemotactic re-
sponse is illustrated in Figs. 2A and 2B, respectively. Che-
motactic activity was detected only in cultures synthesiz-
ing type X collagen (Table 1). Using chondrocytes from ®ve
different aged fetuses, chemotactic activity was ®rst ob-
served at 0±2 days in the A subpopulation and then at 2±
4 days in the B subpopulation accompanying the synthesis
of type X collagen. Cultures of subpopulations C (6±8 days)
and D/E (8±10 days) took longer before type X collagen was
synthesized. In the C and D/E subpopulations, chemotactic
activity was detected after type X collagen synthesis was
®rst detected at 8±10 and 10±12 days, respectively (Table
1). Chondrocyte subpopulations from older fetuses (220±
240 days) produced chemotactic activity after shorter peri-
ods of culture compared to younger fetuses (190±210 days).
Partial puri®cation and characterization of the chemo-
tactic molecule. Large volumes (100±500 ml) of condi-
tioned serum-free media, which tested positive for the pres-
ence of the chemotactic molecule, were ultra®ltered using
YM-1 membranes. Neither the retentate nor the ®ltrate
FIG. 2. Example of checkerboard analysis for chemotactic activity were found to contain chemotactic activity, suggesting
in culture media. (A) Positive chemotactic activity. Chondrocyte binding to the ®lter. The YM-1 membrane was washed with
serum-free conditioned medium from the A cell subpopulation was 2 M NaCl in Tris±HCl, pH 7.4, overnight at 47C. After
collected on Day 2 (0±2). The lower and upper wells of the Boyden desalting with 70% ethanol the chemotactic activity was
chamber were ®lled with various dilutions of the medium. The recovered. This material was puri®ed ®rst using a Bio-Gel P-
upper chamber also received 2 1 104 endothelial cells per well (for 30 gel ®ltration column (data not shown) and subsequently
details see Materials and Methods). By increasing the concentration
through a reverse-phase HPLC column (Fig. 3A). The Bio-of the chondrocyte serum-free conditioned medium in the wells of
Gel P-30 chemotactic-positive fractions were collected atthe lower chamber (with a ®xed concentration in the upper cham-
and beyond the Vt , indicating that the molecule was of anber), an increased EC migration to the lower chamber is observed.
apparent low molecular mass (Mr below 5 1 103) and/or was(B) Absence of chemotactic activity. Serum-free conditioned me-
dium from the B cell subpopulation was collected on Day 2 (0±2). weakly bound to the gel. The HPLC fractions that contained
No effect on the number of EC that have migrated to the lower chemotactic activity (Fig. 3B) were pooled and tested for the
chamber is observed when the concentration of the chondrocyte ability to induce EC proliferation. There was no effect on
serum-free conditioned medium in the wells of the lower chamber EC proliferation (Fig. 4).
is progressively increased. The mean { S.D. of the number of EC
per 7.1 mm2 is shown.
TABLE 1
The Presence (/) or Absence (0) of Chemotactic Activity for EC
synthesis increased in the A subpopulation. Type X collagen and Type X Collagen (X) in the Culture Media
was ®rst observed in the B subpopulation at 4±6 days and
Dayslater in the C subpopulation at 8±10 days and the D/E sub-
populations at 12±14 days. The time of appearance of type
0±2 2±4 4±6 6±8 8±10 10±12X collagen was dependent on fetal age. The synthesis of
type X collagen corresponded to an increase in cell size as Chondrocyte
the cells underwent hypertrophic changes revealed by light subpopulations
and electron microscopy (Alini et al., 1994). Matrix calci®- A /
Xcation occurred in the same sequential order as observed
B 0 /for type X collagen synthesis but always 1 to 3 days after
Xthe synthesis of this molecule (data not shown; Alini et al.,
C 0 0 0 0 /1994).
X XProduction of a chemotactic molecule during expression
D/E 0 0 0 0 0 /of the hypertrophic phenotype. To detect the production
X X
of an EC chemotactic factor by chondrocytes and to deter-
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FIG. 5. SDS±PAGE analysis of HPLC-puri®ed chemotactic mole-
cules. Chemotactic-positive fractions, from reverse-phase HPLC
shown in Fig. 3, were combined, lyophilized, washed with 70%
ethanol, and analyzed under reducing conditions using 4±20% gra-
dient gels followed by staining with Coomassie blue. HPLC frac-
tions (lane 1); Mr standards (lane 2).
SDS±PAGE analysis and chemotactic activity of eluted
protein. Chemotactic-positive HPLC fractions were pooled,
lyophilized, washed with 70% ethanol, and analyzed underFIG. 3. Reverse-phase HPLC pro®le of chemotactic-positive culture
reducing conditions using SDS±PAGE. A large protein of anmedium (2 M NaCl eluate from the YM-1 membrane) dissolved in
0.1% tri¯uoroacetic acid and chromatographed as described under Ma- approximate Mr of 120 1 103 was detected in these fractions
terials and Methods. (A) A major peak was observed at 214 nm. (B) by Coomassie blue staining (Fig. 5). This indicated that the
HPLC fractions (34±39, corresponding to the retention time of 33±39 molecule was weakly bound to the Bio-Gel P-30. Following
min in A) were collected, lyophilized, redissolved in 300 ml deionized transfer and subsequent elution from PVDF membrane, the
water, and tested for EC chemotactic activity at 1:30 dilution. Strong protein of Mr 120 1 103 was observed to stimulate EC migra-chemotactic activity was observed in fractions 35±38.
tion using the Boyden chamber assay compared to that of the
BSA and blank gel elution controls (Table 2).
In vivo angiogenesis. To determine if the chemotactic-
positive HPLC samples were capable of inducing angiogene-
TABLE 2
Stimulation of EC Migration by Proteins and Blank Gel Control
Following SDS±PAGE and Elution from PVDF Membranes
EC per 7.1 mm2 (mean { S.D.)
Eluted Eluted
120-kDa Eluted blank
Dilution protein BSA gel
0 86 { 7 93 { 5 90 { 3
1/64 112 { 2 87 { 2 92 { 1
1/32 138 { 7 82 { 1 87 { 4
1/16 129 { 2 80 { 4 90 { 3
FIG. 4. Stimulation of EC proliferation by doubling dilutions of 1/8 136 { 3 78 { 3 72 { 3
HPLC-puri®ed, chemotactic-positive fractions. These were added 1/4 159 { 1 87 { 5 83 { 6
to the culture medium of bovine EC for 48 hr. No signi®cant effect 1/2 137 { 8 86 { 3 82 { 3
on EC proliferation was observed.
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sis in vivo, the rabbit cornea assay was used. Figure 6A case, the ingrowth of vessels follows cellular hypertrophy
(Floyd et al., 1987). These observations strongly suggest thatshows the induction of corneal neovascularization after 10
days implantation of 300 ng of the chemotactic peptide in an angiogenic molecule is released from hypertrophic chon-
drocytes. Our present studies clearly reveal that an angio-a methacrylate pellet. This effect was also observed when
200 or 100 ng samples were implanted in the rabbit cornea. genic molecule is produced when cells ®rst express the hy-
pertrophic phenotype. This ®ts with the observation thatThis observation was reproduced in six rabbits on different
occasions using two different preparations of the chemotac- vascular ingrowth into the forming secondary center of ossi-
®cation is only observed after cellular hypertrophy (Floydtic molecule. In contrast, rabbit corneas implanted with
control pellets did not exhibit angiogenic responses (Fig. et al., 1987).
Our analyses provide evidence that a high-molecular-6B). Histological studies revealed an absence of in¯amma-
tory in®ltrate suggesting a direct angiogenic effect on EC weight angiogenic protein (Mr , 120,000) is produced by hy-
pertrophic chondrocytes. Although the molecule is chemo-(data not shown).
Modulation of the angiogenic molecule production by tactic for endothelial cells (and this permitted its identi®-
cation and isolation), surprisingly, it is not mitogenic. Othervitamin-D3 metabolites. The B and C chondrocyte sub-
populations were cultured for 48-hr periods with various angiogenic molecules such as bFGF, aFGF, TGF-a, and
platelet-derived endothelial cell growth factor are mitogenicconcentrations of 1,25-(OH)2D3, 24,25-(OH)2D3 or both at
1008, 10010, and 10012 M under serum-free conditions follow- whereas angiogenin is not (Folkman and Shing, 1992). How-
ever, these molecules are much smaller than the moleculeing different periods of culture in the presence of 10% FCS.
Media were compared for their ability to induce EC migra- we describe here. Yet the molecule has a potency (nanogram
amounts) in the rabbit cornea assay similar to that of othertion using the Boyden chamber assay. This experimental
protocol allowed us to investigate the effect of the vitamin- angiogenic molecules such as basic and acid FGF and TGF-
a (Folkman and Shing, 1992). This molecule may corre-D3 metabolites on the production of the angiogenic mole-
cule at different maturational stages, namely prehypertro- spond to the angiogenic activity described (in abstract form)
by Howell et al. (1989). It is novel, however, being signi®-phic (no type X collagen synthesis), early hypertrophic (type
X collagen synthesis but no calci®cation), and advanced cantly larger than the ESAF reported by others in the growth
plate (Brown et al., 1987; Brown and Weiss, 1988; Weiss ethypertrophic states (type X collagen production and matrix
calci®cation). An increase in EC migration was observed al., 1979), the identity of which has yet to be established.
The angiogenic molecule described in this paper waswith both vitamin-D3 metabolites (alone or in combination)
at Day 5 (early hypertrophic stage) at all of the concentra- found only in conditioned medium from chondrocytes that
were expressing the hypertrophic phenotype. The synthesistions tested (Fig. 7). The maximal production of the angio-
genic molecule by the Vitamin-D3-stimulated B chondro- of this molecule may therefore be switched on when chon-
drocytes undergo hypertrophy. Alternatively, it may havecyte subpopulation was observed at Day 7. In contrast, at
a more advanced hypertrophic stage (Day 8), at the time been synthesized at an earlier stage of growth-plate chon-
drocyte differentiation and stored within the extracellularat which matrix calci®cation occurred, a reduction in EC
migration was observed with vitamin-D3 metabolites at all matrix. The importance and the role of the extracellular
matrix in the storage and release of different biological fac-concentrations compared to the control (vehicle alone),
which expressed maximal activity at Day 8. The same effect tors have been recognized for a long time (for review see
Ruoslahti, 1989; Ruoslahti and Yamaguchi, 1991). Recently,was also observed with the less mature (on isolation) C
cell subpopulation, but it occurred at a later time (data not Descalzi Cancedda et al. (1995) demonstrated that an angio-
genic activity was present in the conditioned medium ofshown).
chicken hypertrophic chondrocytes. Interestingly, the an-
giogenic activity described by these authors was detected
only when cells were cultured in the presence of ascorbicDISCUSSION
acid and thus able to assemble an extensive extracellular
matrix. It is well established that the hypertrophic cellsGrowth-plate neovascularization is a key physiological
event in endochondral bone formation. This can be best are capable of rapidly degrading their extracellular matrix,
leading to an enlargement in cell volume. This results inobserved in primary growth plates where the increased in-
growth of capillaries and capillary sprouts (Arsenault, 1987; part from the degradation and loss of type II collagen (Alini
et al., 1992) which is accompanied by a net increase in theSchenk et al., 1967, 1968) is closely associated with the
destruction of the largely uncalci®ed transverse septa and synthesis of collagenase, 72-kDa gelatinase, and stromely-
sin-1 over TIMP-1 synthesis (Dean et al., 1985; Brown etremoval of some of the calci®ed longitudinal septa. The
remaining calci®ed trabeculae serve as a scaffold onto al., 1989; Ballock and Reddi, 1994).
Vitamin-D de®ciency affects endochondral ossi®cationwhich osteoblasts can then settle and form woven bone.
The highly polarized ingrowth of vessels into the hyper- resulting in rickets. Characteristics of this condition are the
impairment of calci®cation and a lengthened hypertrophictrophic zone and toward hypertrophic cells is also observed
in fracture repair and as the secondary centers of ossi®cation zone of the growth plate. Vitamin D has been shown to
exert a direct effect on the metabolism of growth-plateform in the epiphyses of developing long bones. In the latter
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and ®bronectin (Gersternfeld et al., 1990). Together, 1,25-
(OH)2 and 24,25-(OH)2 vitamin D3 can maximally stimulate
matrix calci®cation in healthy rat growth-plate chondro-
cyte cultures (Hinek and Poole, 1988). However, in rachitic
(vitamin-D de®cient) rats, only 24,25-(OH)2 vitamin D3 is
required to stimulate calci®cation. Receptors for 1,25-(OH)2
vitamin D3 are present on growth-plate chondrocytes, with
receptor density being highest in hypertrophic cells (Iwa-
moto et al., 1989). Autoradiographic studies with 24,25-
(OH)2 vitamin D3 have suggested that a separate receptor
exists for this metabolite in growth-plate cells of the prolif-
erative zone (Fine et al., 1985).
The observations reported here, that both 1,25-(OH)2 and
24,25-(OH)2 vitamin D3 singly or together can stimulate
production of this molecule in cultures of hypertrophic
chondrocytes when they ®rst express the hypertrophic phe-
notype (synthesize type X collagen), indicate that the devel-
opment of rickets in vitamin-D de®ciency (Howell and
Dean, 1992) may be related (in part at least) to a de®ciency
of this angiogenic molecule. The appearance of receptors
for vitamin D3 (1,25-(OH)2D3) on hypertrophic chondrocytes
(Iwamoto et al., 1989) would explain the sensitivity of these
cells to these metabolites. Interestingly, at later stages of
maturation of the hypertrophic phenotype, the stimulatory
effect of vitamin-D3 metabolites was lost. This ®ts again
with the observation made by Iwamoto et al. (1989) that
the receptors for 1,25-(OH)2D3 decreased in content once
calci®cation was well established (advanced hypertrophic
stage). The possibility that 24,25-(OH)2 vitamin D3 , which
most potently stimulates calci®cation in culture (Hinek
and Poole, 1988), also shares this receptor is presently under
investigation.
Clearly, regulation by vitamin D3 is complex, is matura-
tion-dependent, and requires further careful studies. How-
ever, the establishment of this culture system which sepa-
rates growth-plate chondrocytes into distinct develop-
mental stages (prehypertrophic, early hypertrophic, and
advance hypertrophic), enabled us to isolate this molecule
and investigate its regulation.FIG. 7. Effect of vitamin-D3 metabolites on the production of the
chemotactic/angiogenic molecule by the B chondrocyte subpopula-
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